DE69434652D1 - Antikonvulsive pseudofructopyranose sulfamate - Google Patents

Antikonvulsive pseudofructopyranose sulfamate

Info

Publication number
DE69434652D1
DE69434652D1 DE69434652T DE69434652T DE69434652D1 DE 69434652 D1 DE69434652 D1 DE 69434652D1 DE 69434652 T DE69434652 T DE 69434652T DE 69434652 T DE69434652 T DE 69434652T DE 69434652 D1 DE69434652 D1 DE 69434652D1
Authority
DE
Germany
Prior art keywords
pseudofructopyranose
anticonvulsive
sulfamate
disclosed
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69434652T
Other languages
English (en)
Other versions
DE69434652T2 (de
Inventor
J Costanzo
E Maryanoff
F Mccomsey
O Nortey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/337,597 external-priority patent/US5498629A/en
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of DE69434652D1 publication Critical patent/DE69434652D1/de
Application granted granted Critical
Publication of DE69434652T2 publication Critical patent/DE69434652T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Confectionery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DE69434652T 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranose sulfamate Expired - Fee Related DE69434652T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17339993A 1993-12-23 1993-12-23
US337597 1994-11-10
US08/337,597 US5498629A (en) 1993-12-23 1994-11-10 Anticonvulsant pseudofructopyranose sulfamates
PCT/US1994/014591 WO1995017406A1 (en) 1993-12-23 1994-12-15 Anticonvulsant pseudofructopyranose sulfamates
US173399 1998-10-15

Publications (2)

Publication Number Publication Date
DE69434652D1 true DE69434652D1 (de) 2006-05-04
DE69434652T2 DE69434652T2 (de) 2007-03-01

Family

ID=26869093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434652T Expired - Fee Related DE69434652T2 (de) 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranose sulfamate

Country Status (13)

Country Link
EP (1) EP0736029B1 (de)
JP (1) JP3555032B2 (de)
AT (1) ATE319715T1 (de)
AU (1) AU695336B2 (de)
CA (1) CA2179733C (de)
DE (1) DE69434652T2 (de)
DK (1) DK0736029T3 (de)
ES (1) ES2260761T3 (de)
IL (1) IL112098A (de)
NZ (1) NZ277725A (de)
PT (1) PT736029E (de)
RU (1) RU2139875C1 (de)
WO (1) WO1995017406A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
ES2252033T3 (es) 1999-07-26 2006-05-16 Ortho-Mcneil Pharmaceutical, Inc. Derivados monosacarido triciclicos utiles para tratar la neurogeneracion inducida por isquemia aguda.
US20030092636A1 (en) * 2001-11-06 2003-05-15 Silberstein Stephen D. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7060725B2 (en) 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (ko) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
TW200812573A (en) 2006-05-19 2008-03-16 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders
US8809385B2 (en) 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US9937145B2 (en) * 2013-12-12 2018-04-10 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compound for use in preventing or treating epilepsy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
EP0736029B1 (de) 2006-03-08
DK0736029T3 (da) 2006-05-15
CA2179733A1 (en) 1995-06-29
JPH09507070A (ja) 1997-07-15
AU695336B2 (en) 1998-08-13
NZ277725A (en) 1998-04-27
DE69434652T2 (de) 2007-03-01
AU1306795A (en) 1995-07-10
CA2179733C (en) 2007-03-27
WO1995017406A1 (en) 1995-06-29
IL112098A0 (en) 1995-03-15
RU2139875C1 (ru) 1999-10-20
ES2260761T3 (es) 2006-11-01
ATE319715T1 (de) 2006-03-15
JP3555032B2 (ja) 2004-08-18
IL112098A (en) 1997-07-13
PT736029E (pt) 2006-05-31
EP0736029A1 (de) 1996-10-09

Similar Documents

Publication Publication Date Title
MX9707453A (es) Derivados de quinazolina.
SE9504661D0 (sv) New compounds
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
ATE36149T1 (de) Antikonvulsive sulfamatderivate.
ATE306261T1 (de) Antithrombosemittel
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
DE69705300T2 (de) Cyclopropylalkansäurederivate
EA200100983A1 (ru) Производные 13-метилэритромицина
UY24625A1 (es) Derivados de la 4-hidroxi-piperidina
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
ATE127452T1 (de) Poly-4-aminopyrrole-2-carboxamide derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
EP1019047A4 (de) Antithrombotische mittel
NO980296D0 (no) Forbedrede terapeutiske midler
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9504662D0 (sv) New compounds
DE69330601T2 (de) Serotoninergische ergolin derivate
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EP1027051A4 (de) Antithrombotische mittel

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ORTHO-MCNEIL PHARMACEUTICAL, INC., RARITAN, N.J.,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee